RecruitingNCT07390136
Sparking Potential, Revealing Infant Neurocognitive Traits
SPRINT: Sparking Potential, Revealing Infant Neurocognitive Traits
Sponsor
University of Wisconsin, Madison
Enrollment
200 participants
Start Date
Jul 30, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This research focuses on the long-term cognitive development of children, including healthy infants and those who had a perinatal brain injury. As part of this research study, children complete virtual game and assessments. Parents will be asked to fill out questionnaires about their child's behavior and stress in the home. All study visits will take place online via Zoom.
Eligibility
Min Age: 3 MonthsMax Age: 24 Months
Inclusion Criteria7
- Child-parent dyads will be recruited to the study.
- Children 3-24 months with and without a history of a perinatal brain injury (PBI) will be included in this study.
- Children with PBIs will include:
- Children diagnosed during the neonatal period with hypoxic-ischemic encephalopathy,
- Children born at a premature gestational age (born at less than 32 weeks gestational age).
- Children diagnosed with cerebral palsy
- healthy infants with no prior neurological (brain disorder) history
Exclusion Criteria7
- Healthy infants to be included in the control group will not have:
- a prior history of brain injury
- a diagnosis of cerebral palsy
- a history of a neurological disorder
- prior admission to the Neonatal Intensive Care Unit (NICU)
- Children with chromosomal abnormalities, genetic syndromes and major congenital malformations will be excluded from both the patient groups and the control group.
- Parents will have no exclusionary criteria.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07390136
Related Trials
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
NCT065643893 locations
Effects of Food Intake Sequence on Substrate Utilisation and Endurance Performance
NCT075039901 location
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
NCT072147664 locations
A Phase I, Open-label, Crossover Study Comparing the Relative Bioavailability of a Fixed-Dose Combination of Laroprovstat/Rosuvastatin vs Their Single Therapy Products in Healthy Adults
NCT073166082 locations
A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function
NCT072319914 locations